Cytosine Arabinoside (NSC 63878) Toxicity and Antitumor Activity in Human Solid Tumors

Cytosine arabinoside was administered to 449 patients with a variety of solid tumors. The phase I study included doses of 0.8–3.5 mg/kg × 10 days, and a small number received 5 mg/kg daily for the fir